|
Morris, D J; Souness, G W; Brem, A S et al. (2000) Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues. Kidney Int 57:1370-3
|
|
Morris, D J; Latif, S A; Rokaw, M D et al. (1998) A second enzyme protecting mineralocorticoid receptors from glucocorticoid occupancy. Am J Physiol 274:C1245-52
|
|
Latif, S A; Sheff, M F; Ribeiro, C E et al. (1997) Selective inhibition of sheep kidney 11 beta-hydroxysteroid dehydrogenase isoform 2 activity by 5 alpha-reduced (but not 5 beta) derivatives of adrenocorticosteroids. Steroids 62:230-7
|
|
Morris, D J; Souness, G W (1996) Endogenous 11 beta-hydroxysteroid dehydrogenase inhibitors and their role in glucocorticoid Na+ retention and hypertension. Endocr Res 22:793-801
|
|
Souness, G W; Morris, D J (1996) 11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase, possess hypertensinogenic activity in the rat. Hypertension 27:421-5
|
|
Souness, G W; Latif, S A; Laurenzo, J L et al. (1995) 11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat. Endocrinology 136:1809-12
|
|
Morris, D J (1995) The role of steroid metabolism in protective and specificity conferring mechanisms of mineralocorticoid action. Vitam Horm 50:461-85
|
|
Souness, G W; Myles, K; Morris, D J (1994) Other physiological considerations of protective mechanisms of mineralocorticoid action. Steroids 59:142-7
|
|
Latif, S A; Hartman, L R; Souness, G W et al. (1994) Possible endogenous regulators of steroid inactivating enzymes and glucocorticoid-induced Na+ retention. Steroids 59:352-6
|
|
Morris, D J (1993) Liquorice: new insights into mineralocorticoid and glucocorticoid hypertension. R I Med 76:251-4
|
Showing the most recent 10 out of 24 publications
